Ivabradine and the anti-inflammatory effects in patients with ischemic heart disease

被引：4
作者：
Dominguez-Rodriguez, Alberto [1 ,2 ]
Abreu-Gonzalez, Pedro [3 ]
机构：
[1] Hosp Univ Canarias, Serv Cardiol, Tenerife, Spain
[2] Univ Europea Canarias, Fac Ciencias Salud, La Orotava, Santa Cruz De T, Spain
[3] Univ La Laguna, Dept Ciencias Med Basicas, Unidad Fisiol, Santa Cruz De Tenerife, Spain
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 221卷
关键词：
Angina pectoris; Anti-anginal drug; Ivabradine; Coronary artery disease; Anti-inflammatory; ACUTE CORONARY SYNDROMES; C-REACTIVE PROTEIN; RATE REDUCTION; ATHEROSCLEROSIS; INFLAMMATION; DYSFUNCTION; MORTALITY; RISK;
D O I：
10.1016/j.ijcard.2016.07.096
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：627 / 628
页数：2
相关论文
共 13 条
[1]   Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice [J].
Baumhaekel, Magnus ;
Custodis, Florian ;
Schlimmer, Nils ;
Laufs, Ulrich ;
Boehm, Michael .
ATHEROSCLEROSIS, 2010, 212 (01) :55-62
[2]   Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction [J].
Camici, Paolo G. ;
Gloekler, Steffen ;
Levy, Bernard I. ;
Skalidis, Emmanouil ;
Tagliamonte, Ercole ;
Vardas, Panos ;
Heusch, Gerd .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 :1-6
[3]   Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice [J].
Custodis, Florian ;
Baumhaekel, Magnus ;
Schlimmer, Nils ;
List, Franka ;
Gensch, Christoph ;
Boehm, Michael ;
Laufs, Ulrich .
CIRCULATION, 2008, 117 (18) :2377-2387
[4]   Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation [J].
Dominguez-Rodriguez, A. ;
Abreu-Gonzalez, P. ;
Kaski, J. C. .
CURRENT DRUG TARGETS, 2009, 10 (10) :1001-1008
[5]   Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study [J].
Dominguez-Rodriguez, Alberto ;
Consuegra-Sanchez, Luciano ;
Blanco-Palacios, Gabriela ;
Abreu-Gonzalez, Pedro ;
Sanchez-Grande, Alejandro ;
Bosa-Ojeda, Francisco ;
Kaski, Juan Carlos .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) :160-162
[6]   Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy [J].
Dominguez-Rodriguez, Alberto ;
Blanco-Palacios, Gabriela ;
Abreu-Gonzalez, Pedro .
WORLD JOURNAL OF CARDIOLOGY, 2011, 3 (04) :101-104
[7]   Heart rate variability and progression of coronary atherosclerosis [J].
Huikuri, HV ;
Jokinen, V ;
Syvänne, M ;
Nieminen, MS ;
Airaksinen, KEJ ;
Ikäheimo, MJ ;
Koistinen, JM ;
Kauma, H ;
Kesäniemi, AY ;
Majahalme, S ;
Niemelä, KO ;
Frick, MH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) :1979-1985
[8]   HEART-RATE AND CARDIOVASCULAR MORTALITY - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
KANNEL, C ;
PAFFENBARGER, RS ;
CUPPLES, LA .
AMERICAN HEART JOURNAL, 1987, 113 (06) :1489-1494
[9]   Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein [J].
Koenig, W .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (02) :199-206
[10]   C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy [J].
Morrow, DA ;
Rifai, N ;
Antman, EM ;
Weiner, DL ;
McCabe, CH ;
Cannon, CP ;
Braunwald, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1460-1465
12